| 000 | 01011 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515044607.0 | ||
| 264 | 0 | _c20070103 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a1873-5592 | ||
| 024 | 7 |
_a10.2174/138945006778559120 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKofler, D M | |
| 245 | 0 | 0 |
_aCurrent status of immunotherapy in B cell malignancies. _h[electronic resource] |
| 260 |
_bCurrent drug targets _cOct 2006 |
||
| 300 |
_a1371-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunization, Passive _xmethods |
| 650 | 0 | 4 |
_aImmunotherapy, Active _xmethods |
| 650 | 0 | 4 | _aLeukocyte Transfusion |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xgenetics |
| 700 | 1 | _aMayr, C | |
| 700 | 1 | _aWendtner, C-M | |
| 773 | 0 |
_tCurrent drug targets _gvol. 7 _gno. 10 _gp. 1371-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138945006778559120 _zAvailable from publisher's website |
| 999 |
_c16647878 _d16647878 |
||